Study Population
The study targets 3 groups of early lymphoproliferative disorders:
- Monoclonal B-cell lymphocytosis and asymptomatic Chronic Lymphocytic Leukaemia
- IgM Monoclonal gammopathy and asymptomatic Waldenström’s macroglobulinaemia
- IgA or IgG Monoclonal gammopathy and smouldering myeloma
Status
Recruitment closed, in follow up.
Total recruitment: 574 participants.